Pathstone Family Office, LLC Novavax Inc Transaction History

Pathstone Family Office, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $112,980 - $319,930	-1,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $39,370 - $69,750	500 Added 100.0%	1,000 $112,000
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $15,888 - $35,702	200 Added 66.67%	500 $55,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $4,158 - $25,083	300 New	300 $25,000

291

93.3M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $573M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.